Sepsis Diagnostics Market 2022-2027, Global Size, Share, Growth and Competitive Analysis

The latest report published by IMARC Group, titled "Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," offers a comprehensive analysis of the industry, which comprises insights on the sepsis diagnostics market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global sepsis diagnostics market is expected to exhibit a CAGR of 9.2% during 2022-2027.

COVID-19 Impact Analysis:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a Free Sample Copy of This Report: https://www.imarcgroup.com/sepsis-diagnostics-market/requestsample

Industry Overview and Application:

Sepsis is a severe medical condition caused by bacterial, fungal, or viral infection. The existing infection activates an extreme immune system response in the body, including releasing proteins and other chemicals that can trigger extensive inflammation. This inadvertently can cause blood vessel clots, low blood pressure, loss of circulating blood volume, and organ failure. The condition may also result in irregular breathing, neurological dysfunction, and a faster heart rate. The diagnostic procedure for sepsis includes immunoassays, molecular diagnosis, micro fluids, flow cytometry, and biomarkers. Other diagnostic tools, such as chest x-rays, computed tomography (CT) scans, ultrasounds, and magnetic resonance imaging (MRI) scans, are also adopted by medical practitioners to diagnose and determine the severity of the infection.

Market Trends and Drivers:

The increasing demand for sepsis diagnostics across hospitals, academic research institutes, and pathology and reference laboratories can be attributed to the surging number of patients suffering from chronic illnesses and the rising prevalence of hospital-acquired infections (HAIs). In line with this, the widespread adoption of advanced analytic tools to provide real-time data access and accurate disease diagnosis, supported by the increasing healthcare expenditure, is further boosting the sepsis diagnostics market growth. Moreover, the rising prevalence of infectious diseases and extensive research and development (R&D) activities are creating a positive outlook for the market. Apart from this, the emergence of novel molecular and immunological biomarkers that aid in the early diagnosis of sepsis is accelerating the market growth.

Sepsis Diagnostics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the sepsis diagnostics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Abbott Laboratories
• Becton
• Dickinson and Company (BD)
• biomerieux SA
• Bruker Corporation
• EKF Diagnostics Holding Plc
• Epic Systems Corporation
• Luminex Corporation
• Roche Holding AG
• Sysmex Corporation
• T2 Biosystems Inc.

Key Market Segmentation:

The report has segmented the global sepsis diagnostics market on the basis of diagnosis, product, mode of testing, technology, pathogen, end-user and region.

Breakup by Diagnosis:

• Automated Diagnostics
• Conventional Diagnostics

Breakup by Product:

• Instruments
• Assay Kits and Reagents
• Blood Culture Media
• Software

Breakup by Mode of Testing:

• Laboratory Tests
• Point-of-Care Tests

Breakup by Technology:

• Molecular Diagnostics
• Immunoassays
• Biomarkers
• Flow Cytometry
• Microfluidics
• Blood Culture

Breakup by Pathogen:

• Bacterial Sepsis:
o Gram-Positive Bacterial Sepsis
o Gram-Negative Bacterial Sepsis

• Viral Sepsis
• Fungal Sepsis
• Others

Breakup by End User:

• Diagnostic Clinics
• Hospitals
• Research Laboratories

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3090&flag=C

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.